Salvage therapy and efavirenz application after failure of highly active antiretroviral therapy in patients with severe immunodeficiency

被引：0
|
作者：
Muratori, DS [1 ]
Mezzaroma, I [1 ]
Cascioli, C [1 ]
Ensoli, F [1 ]
Fantini, R [1 ]
Barbone, B [1 ]
Aiuti, F [1 ]
机构：
[1] Univ La Sapienza, Dipartimento Med Clin, Cattedra Immunol Clin & Allergol, Rome, Italy
来源：
TWELFTH NATIONAL CONVENTION: AIDS AND RELATED SYNDROMES | 2000年
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：203 / 208
页数：6
相关论文
共 50 条
  • [1] Salvage therapy and formulation of highly active antiretroviral therapy
    Fessel, WJ
    Follansbee, SE
    Young, TP
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 24 (02): : 194 - 195
  • [2] Severe hypertriglyceridaemia associated with human immunodeficiency virus and highly active antiretroviral therapy
    Carling, RS
    Hextall, R
    DeSilva, PA
    Barth, JH
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2002, 39 : 409 - 413
  • [3] Immunological Response of Human Immunodeficiency Virus Positive Patients after Initiation of Highly Active Antiretroviral Therapy
    Reddy, K. B. Yadavendra
    Visalakshi, B.
    Kirankumar, P.
    [J]. INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY, 2015, 3 (07) : 117 - 120
  • [4] Genotypic resistance to antiretroviral drugs in patients with therapeutic failure to highly active antiretroviral therapy
    Gutiérrez, F
    Moltó, J
    Escolano, C
    Mora, A
    Pasquau, F
    Gregori, J
    Nogueira, E
    [J]. MEDICINA CLINICA, 2000, 115 (11): : 401 - 404
  • [5] Highly active antiretroviral therapy and human immunodeficiency virus encephalitis
    Cook, JE
    Dasgupta, S
    Middaugh, LD
    Terry, EC
    Gorry, PR
    Wesselingh, SL
    Tyor, WR
    [J]. ANNALS OF NEUROLOGY, 2005, 57 (06) : 795 - 803
  • [6] Highly active antiretroviral therapy with efavirenz: long-term metabolic effects
    Roca, B
    Ferrero, JA
    Marco, JM
    Lapuebla, C
    [J]. ANTIVIRAL THERAPY, 2002, 7 (03) : L32 - L32
  • [7] Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (HAART)
    Kumar, N. Sum
    Shashibhushan, J.
    Malappa
    Venugopal, K.
    Vishwanatha, Hugo
    Menon, Mahesh
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (07) : 5 - 8
  • [8] Highly Active Antiretroviral Therapy-Associated Ptosis in Patients With Human Immunodeficiency Virus
    Silkiss, Rona Z.
    Lee, Han
    Ray, Vincent L. Gills
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2009, 127 (03) : 345 - 346
  • [9] Lupus anticoagulant in human immunodeficiency virus -infected patients on highly active antiretroviral therapy
    Awodu, Omolade A.
    Olayemi, Edeghonghon E.
    Bazuaye, Godwin N.
    Onunu, Abel N.
    [J]. INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2010, 53 (01) : 47 - 49
  • [10] Prevalence of Nephrolithiasis in Human Immunodeficiency Virus Infected Patients on the Highly Active Antiretroviral Therapy
    Raheem, Omer A.
    Mirheydar, Hossein S.
    Palazzi, Kerrin
    Chenoweth, Marianne
    Lakin, Charles
    Sur, Roger L.
    [J]. JOURNAL OF ENDOUROLOGY, 2012, 26 (08) : 1095 - 1098
12345